查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1993872

下一代生物製造市場：依工作流程、應用、產品類型、最終用途、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Next-Generation Biomanufacturing Market, By Workflow Type, By Application, By Product, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年，下一代生物製造市場價值為 443.8039 億美元，預計從 2026 年到 2033 年將以 6.81% 的複合年成長率成長。

下一代生物製造是指利用先進技術和尖端生產方法生產疫苗、單株抗體、基因療法和其他生物製藥等生物製藥製品。與通常依賴大規模、耗時批次製程的傳統生物製造不同，這些方法強調更靈活、高效和擴充性的生產系統。連續生物製程、一次性生物反應器、自動化、數位化監控和先進的細胞培養技術等，有助於提高生產效率和產品品質的穩定性，同時滿足腫瘤學、罕見疾病和個人化醫療等領域對複雜生物製藥日益成長的需求。隨著生物製藥需求的持續成長，以及製藥公司採用先進製造技術來支援專業化生產流程，下一代生物製造市場正在穩步發展。此外，生物技術研發投入的增加、生物製藥生產設施的擴建以及生物技術公司與契約製造組織（CMO）之間的合作，都促進了這些技術在現代生物製藥製造中的更廣泛應用。

下一代生物製造市場—市場動態

全球對生物製藥和先進治療方法的需求日益成長

下一代生物製造市場的主要驅動力是全球對生物製藥（包括單株抗體、疫苗以及基因和細胞療法）需求的快速成長。隨著醫療保健系統越來越依賴先進的生物療法來治療癌症、自體免疫感染疾病等疾病，製藥公司需要更有效率、擴充性生產能力的生產技術。與傳統的間歇式生產相比，下一代生物製造方法，例如連續製程、自動化和模組化製造系統，能夠縮短生產週期、提高產品品質並增強營運靈活性。這種不斷成長的需求正在推動上游連續生物製造領域的發展，該領域透過提高營運效率和減少設施面積來支持大規模生物製藥生產，從而推動市場成長。該領域約佔整個市場的45.3%。政府和全球衛生數據也凸顯了生物製藥生產日益成長的重要性。據世界衛生組織（WHO）稱，對靈活和模組化生產技術的投資已使全球生物製藥產能增加了30%以上。同時，美國國立衛生研究院 (NIH) 的報告顯示，連續生物製程可將生產週期縮短高達 50%，從而顯著提高生物製藥的生產效率。這些趨勢表明，對生物製藥日益成長的需求以及政府對先進製造基礎設施投資的不斷增加，正在加速全球對下一代生物製造技術的應用。

下一代生物製造市場—市場區隔分析：

全球下一代生物製造市場按產品、應用、工作流程類型、最終用途和地區進行細分。

根據產品類型，生物製藥市場可分為三大類：連續上游生物製造產品、一次性上游生物製造產品和下游生物製造產品。其中，一次性上游生物製造產品是推動全球下一代生物製造市場發展的主要力量。一次性上游生物製造產品的主要優勢在於降低污染風險、降低營運成本、提高生產柔軟性。這些產品，包括一次性生物反應器、一次性袋裝物料和管路系統，省去了傳統不銹鋼系統所需的複雜清洗和滅菌流程。這項優勢顯著縮短了生產週期，並提高了生產效率。這對於生產單株抗體、疫苗、細胞療法和基因療法的生物製藥公司至關重要。根據美國食品藥物管理局(FDA) 統計，近年來核准的生物製藥和生物相似藥數量穩定成長，推動了對速度更快、適應性更強的生產平台的需求。此外，根據國際藥品製造商協會聯合會（IFPMA）的報告，生技藥品在全球藥物研發管線中正迅速佔據市場佔有率，這促使製造商採用一次性技術來加速生產並快速擴大規模。這些優勢使得一次性上游工程系統成為全球新一代生物製藥設施中最廣泛採用的產品類型。

根據應用領域，市場可分為兩大類：單株抗體、疫苗、重組蛋白和荷爾蒙。單株抗體（mAb）主導地位的主要原因是其在癌症、自體免疫疾病和感染疾病的治療中廣泛應用。生物製藥公司正日益重視單株抗體的研發，這主要得益於其高特異性、強大的治療效果以及不斷成長的全球核准數量。根據美國食品藥物管理局（FDA）統計，近年來核准的生物製劑中，單株抗體佔相當大的比例，反映了全球對抗體療法的需求不斷成長。此外，世界衛生組織（WHO）也強調了單株抗體療法在腫瘤和免疫疾病領域應用的不斷擴大，這增加了對大規模、高效生物製藥製造平台的需求。由於這些治療方法需要高度可控且可擴展的生產流程，製造商正擴大在上游和下游工藝中採用先進的生物製造技術，這進一步鞏固了單株抗體在全球市場的主導地位。

下一代生物製造市場—區域洞察

新一代生物製造市場正經歷著顯著的地理擴張，北美憑藉其成熟的生物技術和製藥公司、先進的研究基礎設施以及完善的管理體制，佔據了重要的市場佔有率。美國透過對生物製藥、細胞和基因療法開發以及尖端製造技術（例如連續生物製程和一次性系統）的投資，為該地區做出了重大貢獻。美國衛生與公眾服務部和國立衛生研究院 (NIH) 等機構的政府計畫和資金也支持先進生物製造能力的發展。同時，歐洲也是該市場的重要區域，這得益於其高度發展的製藥產業和合作研究舉措。德國、英國、瑞士和法國等國積極參與生物製藥的生產和研究，政府計畫、學術機構和合約開發與生產組織 (CDMO) 共同推動了新一代生物製造技術在全部區域穩步應用，提升了其在新一代生物製造領域的重要性。

下一代生物製造市場—國家洞察

在全球下一代生物製造市場中，美國憑藉其成熟的生物技術產業、先進的研究基礎設施以及對生物製藥製造技術的持續投入，處於領先地位。美國擁有眾多生物製藥公司、研究機構和合約研發生產機構（CDMO），這些機構支持生物製藥、疫苗以及細胞和基因療法的研發和生產。政府措施也促進了市場發展。例如，美國衛生與公眾服務部支持了旨在加強國內生物製造能力和促進先進製造技術創新的計畫。此外，學術機構、生物技術公司和研究機構之間的合作正在推動下一代生物製造方法的逐步應用，例如連續生產、自動化和一次性生物製程系統。

目錄

第1章：下一代生物製造市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：下一代生物製造的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：下一代生物製造產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：下一代生物製造市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：下一代生物製造市場趨勢

  • 下一代生物製造市場佔有率分析（2025 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 下一代生物製造市場：依工作流程類型分類

  • 概述
    • 細分市場佔有率分析：依工作流程類型
    • 上游生物製造工作流程
    • 下游生物製造工作流程

第8章：下一代生物製造市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 單株抗體
    • 疫苗
    • 重組蛋白
    • 荷爾蒙
    • 其他

第9章 下一代生物製造市場：依產品分類

  • 概述
    • 基於細分市場的市佔率分析：按產品
    • 連續上游生物製造產品
    • 一次性上游生物製造產品
    • 下游生物製造產品

第10章 下一代生物製造市場：依最終用途分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 生物製藥公司
    • 研究機構
    • 受託研究機構

第11章 下一代生物製造市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第11章：主要供應商分析：下一代生物製造產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
  • Applikon Biotechnology BV (Netherlands),
  • bbi-biotech GmbH (Germany),
  • Danaher Corporation (US),
  • Eppendorf AG (Germany), Esco Group of Companies (US),
  • GEA Group Aktiengesellschaft (Germany),
  • Meissner Filtration Products, Inc. (US),
  • Merck KGaA (Germany),
  • PBS Biotech, Inc. (US),
  • Pierre Guerin (France),
  • Sartorius AG (Germany),
  • Shanghai Bailun Biotechnology Co. Ltd. (China),
  • Solaris Biotechnology Srl. (Italy),
  • Thermo Fisher Scientific Inc. (US),
  • ZETA GmbH (Austria),
  • Other

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6205

Next-Generation Biomanufacturing Market size was valued at US$ 44,380.39 Million in 2025, expanding at a CAGR of 6.81% from 2026 to 2033.

Next-generation biomanufacturing refers to the use of advanced technologies and modern production methods to produce biological products such as vaccines, monoclonal antibodies, gene therapies, and other biopharmaceuticals. Unlike traditional biomanufacturing, which typically relies on large and time-intensive batch processes, these approaches emphasize more flexible, efficient, and scalable production systems. Technologies such as continuous bioprocessing, single-use bioreactors, automation, digital monitoring, and advanced cell-culture techniques help improve manufacturing efficiency and maintain consistent product quality while supporting the increasing demand for complex biologic medicines used in areas such as oncology, rare diseases, and personalized medicine. The Next-Generation Biomanufacturing market is developing steadily as demand for biologic drugs continues to increase and pharmaceutical companies adopt advanced manufacturing technologies to support specialized production processes. In addition, growing investments in biotechnology research, expansion of biopharmaceutical manufacturing facilities, and collaborations between biotechnology firms and contract manufacturing organizations are supporting the wider adoption of these technologies in modern biopharmaceutical production.

Next-Generation Biomanufacturing Market- Market Dynamics

Rising Global Demand for Biologics and Advanced Therapies

A major factor driving the Next-Generation Biomanufacturing Market is the rapidly growing global demand for biologic medicines, including monoclonal antibodies, vaccines, and gene and cell therapies. As healthcare systems increasingly rely on advanced biologic treatments for diseases such as cancer, autoimmune disorders, and infectious conditions, pharmaceutical manufacturers require more efficient and scalable production technologies. Next-generation biomanufacturing methods, including continuous processing, automation, and modular manufacturing systems, enable faster production cycles, higher product quality, and more flexible operations compared with traditional batch manufacturing. This rising demand has strengthened the continuous upstream biomanufacturing segment, which leads the market because it supports large-scale biologics production with improved operational efficiency and a smaller facility footprint. This segment represented approximately 45.3% of the total market share. Government and global health data also emphasize the growing significance of biologics production. According to the World Health Organization (WHO), global biopharmaceutical manufacturing capacity has expanded by over 30% due to investments in flexible and modular production technologies, while the U.S. National Institutes of Health (NIH) reports that continuous bioprocessing can reduce manufacturing cycle times by up to 50%, significantly enhancing efficiency in biologic drug production. These developments indicate that increasing demand for biologics and rising government investment in advanced manufacturing infrastructure are accelerating the global adoption of next-generation biomanufacturing technologies.

Next-Generation Biomanufacturing Market- Segmentation Analysis:

The Global Next-Generation Biomanufacturing Market is segmented on the basis of Product, Application, Workflow Type, End Use, and Region.

The market is divided into three categories based on Product: Continuous Upstream Biomanufacturing Products, Single-Use Upstream Biomanufacturing Products, and Downstream Biomanufacturing Products. The Single-Use Upstream Biomanufacturing Products segment controls the global Next-Generation Biomanufacturing market single-use upstream biomanufacturing products are primarily driven by their ability to reduce contamination risks, lower operational costs, and increase manufacturing flexibility. These products, including disposable bioreactors, single-use bags, and tubing systems, eliminate the need for complex cleaning and sterilization processes required in traditional stainless-steel systems. This advantage significantly shortens production cycles and improves efficiency, which is critical for biopharmaceutical companies producing monoclonal antibodies, vaccines, and cell or gene therapies. According to the U.S. Food and Drug Administration, the number of approved biologics and biosimilar products has increased steadily in recent years, driving demand for faster and more adaptable manufacturing platforms. Additionally, the International Federation of Pharmaceutical Manufacturers & Associations reports that biologics represent a rapidly growing share of global pharmaceutical pipelines, encouraging manufacturers to adopt single-use technologies to accelerate production and scale up quickly. These advantages make single-use upstream systems the most widely adopted product category in next-generation biomanufacturing facilities worldwide.

The market is divided into two categories based on application: Monoclonal Antibodies, Vaccines, Recombinant Proteins, and Hormones. The leadership of monoclonal antibodies (mAbs) is mainly driven by their extensive use in the treatment of cancer, autoimmune disorders, and infectious diseases. Biopharmaceutical companies increasingly prioritize monoclonal antibody development due to their high specificity, strong therapeutic effectiveness, and growing regulatory approvals worldwide. According to the U.S. Food and Drug Administration, monoclonal antibodies account for a significant share of newly approved biologic drugs in recent years, reflecting strong global demand for antibody-based therapies. In addition, the World Health Organization highlights the expanding use of monoclonal antibody treatments in oncology and immune-related diseases, which has increased the need for large-scale and efficient biomanufacturing platforms. Because these therapies require highly controlled and scalable production processes, manufacturers are increasingly adopting advanced upstream and downstream biomanufacturing technologies, thereby strengthening the dominance of the monoclonal antibodies segment in the global market.

Next-Generation Biomanufacturing Market- Geographical Insights

The Next-Generation Biomanufacturing Market shows strong geographical expansion, with North America holding a notable share of the Next-Generation Biomanufacturing market due to the presence of established biotechnology and pharmaceutical companies, advanced research infrastructure, and supportive regulatory systems. The United States contributes significantly to the region through investments in biologics, cell and gene therapy development, and modern manufacturing technologies such as continuous bioprocessing and single-use systems. Government programs and funding from organizations such as the U.S. Department of Health and Human Services and the National Institutes of Health also support the development of advanced biomanufacturing capabilities. At the same time, Europe represents an important region in the market, supported by a well-developed pharmaceutical industry and collaborative research initiatives. Countries including Germany, the United Kingdom, Switzerland, and France are involved in biologics production and biopharmaceutical research, while government programs, academic institutions, and contract development and manufacturing organizations contribute to the steady adoption of next-generation biomanufacturing technologies across the region, strengthening the region's importance in next-generation.

Next-Generation Biomanufacturing Market- Country Insights

In the global Next-Generation Biomanufacturing Market, The United States represents a key country in the Next-Generation Biomanufacturing market due to its well-established biotechnology industry, advanced research infrastructure, and continuous investment in biologics manufacturing technologies. The country hosts numerous biopharmaceutical companies, research institutions, and contract development and manufacturing organizations that support the development and production of biologics, vaccines, and cell and gene therapies. Government initiatives also contribute to market development; for example, the U.S. Department of Health and Human Services has supported programs to strengthen domestic biomanufacturing capabilities and encourage innovation in advanced manufacturing technologies. In addition, collaboration between academic institutions, biotechnology firms, and research organizations supports the gradual adoption of next-generation biomanufacturing methods such as continuous processing, automation, and single-use bioprocessing systems.

Next-Generation Biomanufacturing Market- Competitive Landscape:

The Next-Generation Biomanufacturing Market is intensely competitive and moderately fragmented, with numerous global biotechnology and life sciences companies emphasizing technological innovation, automation, and advanced bioprocessing solutions to enhance their market position. Prominent companies, including Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Sartorius AG, and GE HealthCare, play a crucial role in the industry by providing sophisticated bioreactors, disposable manufacturing systems, and automated platforms for biologics production. These organizations implement strategies such as collaborations, new product introductions, capacity expansions, and strategic acquisitions to enhance manufacturing productivity and scalability. Additionally, key companies are increasingly investing in continuous biomanufacturing technologies, AI-enabled process monitoring, and flexible modular production facilities to meet the rising demand for biologics, biosimilars, and cell and gene therapies globally, thereby intensifying market competition and driving technological progress across the sector.

Recent Developments:

In March 2023, Sartorius AG and LFB Biomanufacturing collaborated on the creation and production of cell lines. LFB BIOMANUFACTURING is a division of LFB Group, a well-known European business that supplies medical practitioners with plasma-derived pharmaceutical products. It specializes in therapeutic protein biomanufacturing. This collaboration strengthens advanced cell line development capabilities and supports the growing demand for efficient biologics manufacturing across the global biopharmaceutical industry.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Applikon Biotechnology BV (Netherlands),
  • bbi-biotech GmbH (Germany),
  • Danaher Corporation (US),
  • Eppendorf AG (Germany), Esco Group of Companies (US),
  • GEA Group Aktiengesellschaft (Germany),
  • Meissner Filtration Products, Inc. (US),
  • Merck KGaA (Germany),
  • PBS Biotech, Inc. (US),
  • Pierre Guerin (France),
  • Sartorius AG (Germany),
  • Shanghai Bailun Biotechnology Co. Ltd. (China),
  • Solaris Biotechnology Srl. (Italy),
  • Thermo Fisher Scientific Inc. (US),
  • ZETA GmbH (Austria),
  • Others

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY WORKFLOW TYPE- MARKET ANALYSIS, 2020 - 2033

  • Upstream Biomanufacturing Workflow
  • Downstream Biomanufacturing Workflow

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Protein
  • Hormones
  • Others

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • Continuous Upstream Biomanufacturing Products
  • Single-Use Upstream Biomanufacturing Products
  • Downstream Biomanufacturing Products

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY End Use- MARKET ANALYSIS, 2020 - 2033

  • Biopharmaceutical Companies
  • Research Institutions
  • Contract Research Organizations

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Next-Generation Biomanufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Next-Generation Biomanufacturing Market Snippet by Workflow Type
    • 2.1.2. Next-Generation Biomanufacturing Market Snippet by Application
    • 2.1.3. Next-Generation Biomanufacturing Market Snippet by Product
    • 2.1.4. Next-Generation Biomanufacturing Market Snippet by End Use
    • 2.1.5. Next-Generation Biomanufacturing Market Snippet by Country
    • 2.1.6. Next-Generation Biomanufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Next-Generation Biomanufacturing Key Market Trends

  • 3.1. Next-Generation Biomanufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Next-Generation Biomanufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Next-Generation Biomanufacturing Market Opportunities
  • 3.4. Next-Generation Biomanufacturing Market Future Trends

4. Next-Generation Biomanufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Next-Generation Biomanufacturing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Next-Generation Biomanufacturing Market Landscape

  • 6.1. Next-Generation Biomanufacturing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Next-Generation Biomanufacturing Market - By Workflow Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Workflow Type, 2025 & 2033 (%)
    • 7.1.2. Upstream Biomanufacturing Workflow
    • 7.1.3. Downstream Biomanufacturing Workflow

8. Next-Generation Biomanufacturing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Monoclonal Antibodies
    • 8.1.3. Vaccines
    • 8.1.4. Recombinant Protein
    • 8.1.5. Hormones
    • 8.1.6. Others

9. Next-Generation Biomanufacturing Market - By Product

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 9.1.2. Continuous Upstream Biomanufacturing Products
    • 9.1.3. Single-Use Upstream Biomanufacturing Products
    • 9.1.4. Downstream Biomanufacturing Products

10. Next-Generation Biomanufacturing Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 10.1.2. Biopharmaceutical Companies
    • 10.1.3. Research Institutions
    • 10.1.4. Contract Research Organizations

11. Next-Generation Biomanufacturing Market- By Geography

  • 10.2. Introduction
    • 10.2.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.3. North America
    • 10.3.1. Overview
    • 10.3.2. Next-Generation Biomanufacturing Key Manufacturers in North America
    • 10.3.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. North America Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.3.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.3.7. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.8. U.S.
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. U.S. Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.8.6. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.9. Canada
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. Canada Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.9.6. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.4. Europe
    • 10.4.1. Overview
    • 10.4.2. Next-Generation Biomanufacturing Key Manufacturers in Europe
    • 10.4.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. Europe Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.4.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.4.7. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.8. Germany
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. Germany Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.8.6. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.9. UK
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. UK Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.9.6. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.10. France
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. France Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.10.6. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.11. Italy
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Italy Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.11.6. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.12. Spain
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Spain Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.12.6. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.13. The Netherlands
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. The Netherlands Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.13.6. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.14. Sweden
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Sweden Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.14.6. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.15. Russia
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Russia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.15.6. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.16. Poland
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Poland Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.16.6. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of Europe
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of the Europe Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.5. Asia Pacific (APAC)
    • 10.5.1. Overview
    • 10.5.2. Next-Generation Biomanufacturing Key Manufacturers in Asia Pacific
    • 10.5.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. APAC Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.5.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.5.7. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.8. China
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. China Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.8.6. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.9. India
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. India Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.9.6. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.10. Japan
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Japan Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.10.6. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.11. South Korea
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. South Korea Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.11.6. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.12. Australia
      • 10.5.12.1. Overview
      • 10.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.12.3. Australia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.12.5. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.12.6. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.13. Indonesia
      • 10.5.13.1. Overview
      • 10.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.13.3. Indonesia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.13.5. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.13.6. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.14. Thailand
      • 10.5.14.1. Overview
      • 10.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.14.3. Thailand Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.14.5. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.14.6. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.15. Philippines
      • 10.5.15.1. Overview
      • 10.5.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.15.3. Philippines Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.15.5. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.15.6. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.16. Rest of APAC
      • 10.5.16.1. Overview
      • 10.5.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.16.3. Rest of APAC Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.16.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.16.5. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.16.6. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.6. Latin America (LATAM)
    • 10.6.1. Overview
    • 10.6.2. Next-Generation Biomanufacturing Key Manufacturers in Latin America
    • 10.6.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. LATAM Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.6.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.6.7. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.8. Brazil
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. Brazil Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.8.6. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.9. Mexico
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Mexico Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.9.6. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.10. Argentina
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Argentina Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.10.6. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.11. Colombia
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Colombia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.11.6. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.12. Rest of LATAM
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Rest of LATAM Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.7. Middle East and Africa (MEA)
    • 10.7.1. Overview
    • 10.7.2. Next-Generation Biomanufacturing Key Manufacturers in Middle East and Africa
    • 10.7.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.7.4. MEA Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.7.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.7.6. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.7.7. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.8. Saudi Arabia
      • 10.7.8.1. Overview
      • 10.7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.8.3. Saudi Arabia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.8.5. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.9. United Arab Emirates
      • 10.7.9.1. Overview
      • 10.7.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.9.3. United Arab Emirates Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.9.5. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.10. Israel
      • 10.7.10.1. Overview
      • 10.7.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.10.3. Israel Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.10.5. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.10.6. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.11. Turkey
      • 10.7.11.1. Overview
      • 10.7.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.11.3. Turkey Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.11.5. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.11.6. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.12. Algeria
      • 10.7.12.1. Overview
      • 10.7.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.12.3. Algeria Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.12.5. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.12.6. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.13. Egypt
      • 10.7.13.1. Overview
      • 10.7.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.13.3. Egypt Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.13.5. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.13.6. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.14. Rest of MEA
      • 10.7.14.1. Overview
      • 10.7.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.14.3. Rest of MEA Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.14.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.14.5. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.14.6. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Next-Generation Biomanufacturing Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
  • 11.3. Applikon Biotechnology BV (Netherlands),
  • 11.4. bbi-biotech GmbH (Germany),
  • 11.5. Danaher Corporation (US),
  • 11.6. Eppendorf AG (Germany), Esco Group of Companies (US),
  • 11.7. GEA Group Aktiengesellschaft (Germany),
  • 11.8. Meissner Filtration Products, Inc. (US),
  • 11.9. Merck KGaA (Germany),
  • 11.10. PBS Biotech, Inc. (US),
  • 11.11. Pierre Guerin (France),
  • 11.12. Sartorius AG (Germany),
  • 11.13. Shanghai Bailun Biotechnology Co. Ltd. (China),
  • 11.14. Solaris Biotechnology Srl. (Italy),
  • 11.15. Thermo Fisher Scientific Inc. (US),
  • 11.16. ZETA GmbH (Austria),
  • 11.17. Other

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us